3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
336
Neoplasms, Plasma Cell
99
Myelodysplastic Syndromes
89
Leukemia, Lymphocytic, Chronic, B-Cell
89
Precursor Cell Lymphoblastic Leukemia-Lymphoma
88
Hodgkin Disease
85
Lymphoma, Non-Hodgkin
84
Leukemia, Myeloid, Acute
83
Lymphoma, Follicular
71
Leukemia
71
Lymphoma
69
Lymphoma, Mantle-Cell
67
Lymphoma, B-Cell, Marginal Zone
63
Burkitt Lymphoma
63
Lymphoma, Large B-Cell, Diffuse
59
Lymphoma, Large-Cell, Immunoblastic
55
Recurrence
52
Myeloproliferative Disorders
49
Leukemia, Myeloid, Chronic-Phase
48
Primary Myelofibrosis
46
Leukemia, Myeloid, Accelerated Phase
43
Leukemia, Myelomonocytic, Chronic
41
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
38
Dendritic Cell Sarcoma, Interdigitating
37
Congenital Abnormalities
35
Blast Crisis
34
Waldenstrom Macroglobulinemia
27
Myelodysplastic-Myeloproliferative Diseases
25
Lymphoma, T-Cell, Cutaneous
25
Immunoglobulin Light-chain Amyloidosis
25
Interventions
fludarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
×
Cyclophosphamide
×
Plasma cell
×
Clear all
NCT04561557
2024-10-30
CARTinNS
Tongji Hospital
Phase EARLY_PHASE1
Recruiting
36 enrolled